|  | |
| Identifiers | |
|---|---|
| 
 | |
| CAS Number | 
 | 
| PubChem CID | |
| Chemical and physical data | |
| Formula | C10H11BrN2O | 
| Molar mass | 255.115 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.[1]
See also
References
- ↑ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. Basel, Switzerland. 27 (18): 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.